Baxter's $4B buyout of Gambro gets OK from Australian regulators

09/6/2013 | MassDevice.com (Boston)

Baxter's acquisition of Gambro, a Swedish maker of dialysis systems, for almost $4 billion has won approval from business regulators in Australia. The decision is contingent on Baxter divesting itself of its renal replacement therapy unit. The acquisition also has the green light from regulators in the U.S., Europe, Canada, Turkey, Ukraine, Brazil, South Korea and China.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA